A
AtriCure
Health Tech & Medtech · West Chester, United States · Founded 1994 · IPO 2005
Talent graph
AtriCure's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on AtriCure's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where AtriCure has talent and traffic
across markets
Patent intelligence
AtriCure’s patent portfolio
148 active families in the valuation dataset.
Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.
Capital deployed
AtriCure's 3 investments and acquisitions.
Every disclosed deal where AtriCure appeared as a backer or acquirer, 2013–2019. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across AtriCure's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
AtriCure's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about AtriCure
An AI-synthesized read of the highest-engagement posts about AtriCure on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AtriCure on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.